1285 a Abdulhafez, M. , 1165–1167 Absence of Eyelids , 1085, 1086

1285 a Abdulhafez, M. , 1165–1167 Absence of Eyelids , 1085, 1086

Index A Ahmadi, M.A. , 581, 600 Abdulhafez, M. , 1165–1167 Ahn, H.B. , 275 Absence of eyelids , 1085, 1086 Ahuero, A.E. , 473–498 A C C . S ee Adenoid cystic carcinoma Ainbinder, D.J. , 1164, 1166 A C E . S ee Angiotensin-converting enzymes Alex, J.C. , 589 Acquired causes, dacryostenosis Alfonso, E.C. , 546 congenital defect, drainage system , 637 Al-Hariri, A. , 207–226 functional dacryostenosis , 631 Allen, C. , 981 impaired tear outfl ow , 630 Allen, J.H. , 1108 infectious mononucleosis , 638 Allen, K. , 694 lower lid ectropion , 640 Allen, L. , 1108 metastatic disease , 642 Allen, R.C. , 283–294 thermal/chemical burns , 642 Allen, S.E. , 313 topical chemotherapeutic medications , 645 ALO. S ee Apraxia of eyelid opening Acquired ptosis Aluminum oxide (Al2 O3 ) anatomy and physiology , 419 biocompatibility implant , 1110 blepharoptosis , 419 ceramic implant biomaterial , 1110 classifi cation , 420–425 and HA implantion , 1114 evaluation , 425–429 polymethylmethacrylate implant , 1146 Acute/chronic sinus disease , 117 porous architecture, FCI , 1110, 1111 Adam, P. , 974 porous orbital implants , 1144 Adams, W. , 87 porous spherical implants , 1113 Adenocarcinoma , 872–873 American Society of Ophthalmic Plastic Adenoid cystic carcinoma (ACC) , 873–875, 920–924 and Reconstructive Surgery (ASOPRS) Adnexal burns founding and charter members , 93 acute treatment prominent oculoplastic surgeons , 92, 93 eyelid , 229 training quality , 92 Masquerade procedure , 231 W. Hughes , 92–93 monocanalicular stents , 230 Amjad, I. , 1232 polymyxin B sulfate , 230 Anatomy prophylactic ocular lubrication , 230 carotid and intracranial ophthalmic arteries , 53–54 sloughing skin , 229 cavernous sinus tarsorrhaphy , 230–231 structures, anterior , 51, 52 description , 229 and venous connections , 51 intermediate care cranial nerves lower and upper lid release incision , 232 abducens , 52, 53 wound healing progress , 231 oculomotor and trochlear , 52 late reconstruction posterior lateral , 52 adjacent tissue skin/myocutaneous fl aps , 232 sagittal section, head , 52 cicatricial contracture and ectropion , 232 trigeminal ganglion , 53 defi nition , 232 dura mater , 50–51 full-thickness skin graft, cicatricial ectropion , 233 eyelid ( see Eyelid anatomy) medial canthal , 233–234 lacrimal secretory and excretory system , 12–20 posterior lamella and lid margin , 233 nasal and paranasal sinuses , 7–12 superfi cial epidermis and thicker dermal layer , 229 optic chiasm , 54 thermal injuries , 229 orbit , 37–49 Adnexal deformities , 1073, 1081 osteology , 3–7 Agatston, S.A. , 399 pertinent intracranial osteology E.H. Black et al. (eds.), Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 1285 DOI 10.1007/978-1-4614-0971-7, © Springer Science+Business Media, LLC 2012 1286 Index Anatomy (cont.) goblet cells, conjunctiva , 1134–1135 cranial fossae and sphenoid contribution , 50 prosthesis irregularities , 1135 optic foramen , 50 socket discharge , 1135 sagittal section, skull , 50, 51 dryness , 1134 sphenoid bone , 50, 51 ectropion , 1139 Anderson, D.D. , 88 enophthalmos ( see Enophthalmos) Anderson, N.G. , 612 enucleation vs. evisceration , 1119 Anderson, R.L. , 29, 311, 345–353, 393, 461, 1145 evisceration indications , 1118–1119 Anel, D. , 88 eyelash misdirection and entropion Anesthesia fornix deepening, graft , 1139 contraindications, sedation , 1267–1268 inferior fornix , 1137, 1139 effi cacy and side-effect profi le , 1265 lower eyelid laxity , 1137 levels, sedation , 1267 implant exposure and extrusion , 1146–1147 nonmedical prevention, anxiety , 1265–1266 implant infection , 1147–1148 pediatric vs. the adult population , 1265 implant migration , 1145 role, sedation , 1265 indications, enucleation , 1118 sedation , 1266–1267 lagophthalmos, prosthesis surface , 1136 sedation choices , 1268–1269 long-term management , 1167 surgery lower eyelid malposition injectable , 1269–1270 inferior fornix shortening , 1137, 1138 PONV , 1270 loss, volume and connective tissue disruption , 1137 postoperative pain control , 1270–1271 mucous membrane graft , 1137, 1138 topical , 1269 ophthalmologist and ocularist , 1131 talking, child’s level , 1266 prosthetic eye , 1131–1134 Aneurysmal bone cyst replacing, diseased eye , 1131 advantages , 861 secondary orbital implantation , 1144–1145 clinical presentation socket characteristics , 1131 left orbit , 861 socket pain , 1136 refractive changes , 861 Anophthalmos and microphthalmos CT scans , 861–862 bony deformities , 1158 histopathology , 862 bulbar conjunctiva and orbital skeleton , 1160 MRI , 862 coloboma/cystic component , 1159, 1160 treatment and prognosis , 862 conformers expanding , 1163 Angiogram , 994, 1002 CT-determined volumetric change , 1166 Angiosarcoma dermis fat grafts , 1164 advantages , 830 “dumbbell” conformers , 1162 clinical presentation , 830 eye and orbit grow , 1161–1162 CT and MRI , 830 facial and orbital development , 1162 histopathology , 830 facial growth , 1161 prognosis , 830–831 hypoplastic orbit , 1166 treatment , 830 infl atable soft tissue , 1164 Angiotensin-converting enzymes (ACE) , 1010 lateral orbitotomy vs. transconjunctival Anolik, R. , 507–516 placement , 1165 Anophthalmic surgery magnetic resonance imaging (MRI) , 1161 acquired socket contracture Mendelian inheritance , 1161 mild , 1150–1151 ophthalmic appliances , 1165 moderate , 1151–1156 orbital tissue expander (OTE) , 1165, 1166 severe , 1156–1158 orbital volume augmentation , 1163 anophthalmos and microphthalmos ( see Anophthalmos and pediatrician and pediatric ophthalmologist , 1161 microphthalmos) porous implants , 1164 anterior orbital cysts , 1136–1137 reconstruction efforts , 1162 artifi cial eye , 1131–1134 self-expanding hydrogel orbital , 1164 associated socket changes systemic malformation , 1161 enucleation and evisceration procedure , 1131–1132 validation, long-term effectiveness , 1167 eyelid laxity , 1132 Ansari, S.A. , 376 intraorbital volume loss , 1132 Anterior approach, ptosis repair orbital fat , 1133 aponeurosis reattachment , 438 post-enucleation syndrome , 1133 autogenous fascia lata , 433–434 preoperative/intraoperative , 1132 Crawford/Masson fascial stripper , 434 prosthesis , 1132 Emla cream , 437 volume, fl uid displaced and implant calculation , 1132–1133 excision, preaponeurotic orbital fat , 440 blepharoptosis ( see Blepharoptosis) Frontalis suspension surgery , 433, 435 complications, implant pegging , 1148–1150 hemostasis , 438 discharge and irritation levator aponeurosis surgery , 436 artifi cial eye , 1135–1136 muscles, leg , 434 droopy left upper lid , 1135 orbital septum , 438 Index 1287 postoperative care , 436 severe hordeolum , 113 Preoperative and postoperative views , 441 upper eyelid chalazion , 113, 114 surgical technique , 436 anaerobic bacteria , 121–122 Apert’s syndrome , 1078 anthrax , 118–119 Apraxia of eyelid opening (ALO) applied corticosteroids , 113 blepharospasm , 350 chancroid , 121 botulinum-A toxin responders , 349 chlamydial , 122 description , 347 chronic meibomitis and seborrheic blepharitis and functional lid deformity , 351 Demodex brevis , 115 neurotoxin therapy , 347 meibomian froth, tear meniscus , 115 Aqueous tear defi ciency (ATD) , 617 seborrheic dermatitis, scalp , 116 Archetypal brainstem ocular motility syndromes , 144 seborrheic marginal blepharitis , 115, 116 Arnold, M.G. , 583 collarettes , 111, 112 Arora, R. , 1153 diphtheria , 119 Arroyo, J.M. , 94 eczematoid dermatitis Arteriovenous malformation (AVM) localized skin abscess and preseptal cellulitis , 117 acquired fi stulas , 994 staphylococci , 116 blood circulation , 993 enteric gram-negative bacteria , 118 diagnosis , 994 eyelid skin cleaning , 113 dynamic virtual imaging , 994–995 inferior corneal micropannus , 111, 112 high-pressure , 993–994 leprosy , 119–120 neurosurgeon , 995 marked lid margin erythema , 111, 112 orbital hemorrhage , 994 staphylococcal , 111 signifi cant hemorrhage , 995 Staphylococcus epidermidis , 111 treatment , 995 streptococcal veins loss , 994 acute cellulitis , 118 Ashton, N. , 612 erysipelas , 118 Asian blepharoplasty impetigo , 117–118 aesthetic goals , 466 syphilis, yaws and pinta , 120–121 anatomy tuberculosis , 119 keloid formation , 463 Bacterial orbital cellulitis levator aponeurosis , 461 classifi cation, surgery , 1007 secondary trichiasis , 462 clinical features complications , 464–466 maxillary sinus , 934 lid crease procedure , 461 paranasal sinus disease , 934 postoperative care , 464 preseptal infection , 934 preoperative evaluation , 463 complications pretarsal orbicularis , 464, 465 antibiotic therapy , 937 suture techniques , 463 cavernous sinus thrombosis (CST) , 938 Aspergillosis , 776 classifi cation system , 937 A T D . S ee Aqueous tear defi ciency corticosteroids , 938 Atopic eczema , 199 frontal sinusitis , 938 Augsburger, J.J. , 1112, 1114, 1280–1281 infection , 937 Autoimmune disorders neurological symptoms , 938–939 Churg–Strauss syndrome (CSS) , 943–944 orbital abscesses , 938 deleterious effects , 1214 polymicrobial infection , 939 granuloma annulare , 944 preexisting cellulitis , 938 Graves’ disease (GD) , 1213 subperiosteal abscess (SPA) , 937–938 hyperthyroidism , 1214 visual loss , 939 orbital sarcoidosis , 941–942 diagnosis Sjögren’s syndrome , 944 CAMRSA , 935 Wegener’s granulomatosis , 942–943 computed tomography (CT) , 934–935 Averbuch-Heller, L. , 143 hypoesthesia , 934 AV M . S ee Arteriovenous malformation magnetic resonance imaging (MRI) , 935 Avoidance of complications , 427, 429 microbiological fl ora , 935 Axial displacement,

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    46 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us